三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

欧美 国产 在线一区三区| 亚洲色欲久久久久综合纲| 亚洲大尺度无码无码专区| 久久久久久AV无码| 免费大片黄在线观看视频| 亚洲国产中文精品线久久| 成人一区二区不卡久久久| 伊人亚洲免费看国产精品| 洪真英av韩国精品三级| 女同互慰亚洲一区二区三区| 神马电影私人久久久久久久| 欧美 日韩 亚洲 激情| 丰满人妻熟妇乱又伦精品| 65日本日韩在线中文字幕| 在线播放无码成动漫视频| 精品久久8x国产免费观看| 亚洲w码和欧洲m码免费| 97久久国产亚洲精品超碰热| 大陆精品偷拍视频在线播放| 天天啪天天操天天干天天日| 国产vivodeshd精品| 日韩一区二区人妻9999| 97久久精品午夜一区二区| 久久精品免费一区二区喷潮| 亚洲国产高清第一第二区| 精品国产高清自在线看超| 天天天天躁天天爱天天碰| 国内精品久久久| 亚洲国产大片一区二区官网| 日本一区二区三区高清欧洲| 中文字幕精品久久久乱码乱码| 中文字幕一区国产日韩在线| 最近日韩精品这里最精品| 久久久亚洲熟妇熟女电影| 大鸡吧骚穴视频在线观看| 国产婷婷av片在线观看| 超薄丝袜足j好爽在线观看| 色婷婷六月亚洲婷婷6月| 日韩一区二区电影免费入口| 国产无遮挡在线播放视频| 亚洲制服师生 中文字幕|